Mark J. Rose

4.2k citations

51 papers · 2.8k · 1 hit paper · h-index 24

Impact in

Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
- Antibiotics Pharmacokinetics and Efficacy
Immunology top 5%
- Biosimilars and Bioanalytical Methods

Papers in

Molecular Biology 16
- Melanoma and MAPK Pathways 3
Oncology 8

Co-authors: Jerome P. Skelly (2 shared papers)Jeffrey Sailstad (2 shared papers)Brian Booth (2 shared papers)Russell Weiner (2 shared papers)C.T. Viswanathan (2 shared papers)Surendra K. Bansal (2 shared papers)Vinod P. Shah (2 shared papers)Anthony J. DeStefano (2 shared papers)
Journals: Journal of Pharmaceutical and Biomedical Analysis (6 papers)The AAPS Journal (4 papers)Journal of Medicinal Chemistry (3 papers)Journal of Chromatography B (3 papers)Journal of Pharmaceutical Sciences (2 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Mark J. Rose

48 papers receiving 2.6k citations

Mark J. Rose's Hit Papers

align trajectories log scale

Quantitative Bioanalytical Methods Validation and Implementation: Best Practices for Chromatographic and Ligand Binding Assays 2007 · 683 citations

Peers

Countries citing papers authored by Mark J. Rose

Since Specialization

Citations

This map shows the geographic impact of Mark J. Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Rose more than expected).

Fields of papers citing papers by Mark J. Rose

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Rose. The network helps show where Mark J. Rose may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark J. Rose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark J. Rose Line = papers co-authored together Mark J. Rose links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Quantitative Bioanalytical Methods Validation and Implementation: Best Practices for Chromatographic and Ligand Binding Assays Pharmaceutical Research ·C.T. Viswanathan, Surendra K. Bansal, Brian Booth, Anthony J. DeStefano, Mark J. Rose, Jeffrey Sailstad, Vinod P. Shah, Jerome P. Skelly, Patrick G. Swann, Russell Weiner Hit paper breakdown →	2007	683
2	Workshop/conference report—Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assays The AAPS Journal ·C.T. Viswanathan, Surendra K. Bansal, Brian Booth, Anthony J. DeStefano, Mark J. Rose, Jeffrey Sailstad, Vinod P. Shah, Jerome P. Skelly, Patrick G. Swann, Russell Weiner	2007	380
3	The Co‐Crystal Approach to Improve the Exposure of a Water‐Insoluble Compound: AMG 517 Sorbic Acid Co‐Crystal Characterization and Pharmacokinetics Journal of Pharmaceutical Sciences ·Annette Bak, Anu Gore, Evelyn Yanez, Mary K. Stanton, Sunita Tufekcic, Rashid Syed, Anna Akrami, Mark J. Rose, Sekhar Surapaneni, Tracy Bostick, A.E. King, Sesha Neervannan, Dražen Ostović, (unknown)	2008	190
4	Platelets are essential for leukocyte recruitment in allergic inflammation Journal of Allergy and Clinical Immunology ·Simon C. Pitchford, Hiroshi Yano, Rebecca Lever, Yanira Riffo‐Vasquez, Silvia Ciferri, Mark J. Rose, Silvia Giannini, Stefania Momi, Domenico Spina, Brian O’Connor, Paolo Gresele, Clive Page	2003	180
5	Interference with Heparin Binding and Oligomerization Creates a Novel Anti-Inflammatory Strategy Targeting the Chemokine System The Journal of Immunology ·Zoë Johnson, Marie Kosco‐Vilbois, Suzanne Herren, R Cirillo, Valeria Muzio, Paola Zaratin, Michela Carbonatto, Matthias Mack, Amir Smailbegovic, Mark J. Rose, Rebecca Lever, Clive Page, Timothy N. C. Wells, Amanda E. I. Proudfoot	2004	131
6	In-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelic variant forms of human liver microsomal cytochrome P450 2C9: correlation with CYP2C9 genotype and in-vivo pharmacokinetics Pharmacogenetics ·Cuyue Tang, Magang Shou, Thomas H. Rushmore, (unknown), Punam Sandhu, Eric Woolf, Mark J. Rose, Alyssa Gelmann, Howard Greenberg, Inge De Lepeleire, Anne Van Hecken, P.J. De Schepper, David L. Ebel, Jules I. Schwartz, A. David Rodrigues	2001	106
7	Photodynamic therapy for treatment of early adenocarcinoma in Barrett's esophagus Gastrointestinal Endoscopy ·Bergein Overholt, Masoud Panjehpour, Elmeria Tefftellar, Mark J. Rose	1993	97
8	Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS Journal of Pharmacological and Toxicological Methods ·Hongyan Li, Mark J. Rose, Linh Tran, Jingwen Zhang, Les P. Miranda, Christopher James, Barbra J. Sasu	2009	92
9	Selective Inhibitors of the Mutant B-Raf Pathway: Discovery of a Potent and Orally Bioavailable Aminoisoquinoline Journal of Medicinal Chemistry ·Adrian L. Smith, Frenel DeMorin, Nick A. Paras, Qi Huang, Jeffrey K. Petkus, Elizabeth M. Doherty, Thomas Nixey, Joseph L. Kim, Douglas A. Whittington, Linda F. Epstein, Matthew R. Lee, Mark J. Rose, Carol Babij, Manory Fernando, Kristen L. Hess, Quynh‐Thu Le, Pedro J. Beltran, Josette Carnahan	2009	91
10	Design and Synthesis of Conformationally Constrained Glucagon-Like Peptide-1 Derivatives with Increased Plasma Stability and Prolonged in Vivo Activity Journal of Medicinal Chemistry ·Les P. Miranda, Katherine A. Winters, Colin V. Gegg, Ankita Patel, Jennifer Aral, Jason Long, Jingwen Zhang, Stephanie Diamond, Mark Guido, Shanaka Stanislaus, Mark Ma, Hongyan Li, Mark J. Rose, Leszek Poppe, Murielle M. Véniant	2008	73
11	Single‐ and Multiple‐Dose Pharmacokinetics of Etoricoxib, a Selective Inhibitor of Cyclooxygenase‐2, in Man The Journal of Clinical Pharmacology ·Nancy Agrawal, Arturo G. Porras, Catherine Z. Matthews, Mark J. Rose, Eric Woolf, Bret J. Musser, Andrea L. Dynder, Katherine E. Mazina, Kenneth C. Lasseter, Thomas L. Hunt, Jules I. Schwartz, Jacqueline B. McCrea, Keith Gottesdiener	2003	71
12	Pharmacokinetics of Anti-hepcidin Monoclonal Antibody Ab 12B9m and Hepcidin in Cynomolgus Monkeys The AAPS Journal ·Jim Xiao, Wojciech Krzyżański, Yow‐Ming Wang, Hongyan Li, Mark J. Rose, Mark Ma, Yuling Wu, Beth Hinkle, Juan José Pérez Ruixo	2010	69
13	Selective and Potent Raf Inhibitors Paradoxically Stimulate Normal Cell Proliferation and Tumor Growth Molecular Cancer Therapeutics ·Josette Carnahan, Pedro J. Beltran, Carol Babij, Quynh‐Thu Le, Mark J. Rose, Steven Vonderfecht, Joseph L. Kim, Adrian L. Smith, Karthik Nagapudi, Martin A. Broome, Manory Fernando, Hue T. Kha, Brian Belmontes, Robert Radinsky, Richard Kendall, Teresa L. Burgess	2010	61
14	Determination of celecoxib in human plasma by normal-phase high-performance liquid chromatography with column switching and ultraviolet absorbance detection Journal of Chromatography B Biomedical Sciences and Applications ·Mark J. Rose, Eric Woolf, B.K. Matuszewski	2000	58
15	EVALUATION OF MICRODOSING STRATEGIES FOR STUDIES IN PRECLINICAL DRUG DEVELOPMENT: DEMONSTRATION OF LINEAR PHARMACOKINETICS IN DOGS OF A NUCLEOSIDE ANALOG OVER A 50-FOLD DOSE RANGE Drug Metabolism and Disposition ·Punam Sandhu, John S. Vogel, Mark J. Rose, Esther A. Ubick, Janice Brunner, Michael A. Wallace, Jennifer K. Adelsberger, Maribeth P. Baker, Paul T. Henderson, Paul G. Pearson, Thomas A. Baillie	2004	47
16	Heparanase induces inflammatory cell recruitment in vivo by promoting adhesion to vascular endothelium American Journal of Physiology-Cell Physiology ·Rebecca Lever, Mark J. Rose, Edward A. McKenzie, Clive Page	2014	44
17	Synthesis and Evaluation of Imidazole Acetic Acid Inhibitors of Activated Thrombin-Activatable Fibrinolysis Inhibitor as Novel Antithrombotics Journal of Medicinal Chemistry ·James C. Barrow, Philippe G. Nantermet, Shaun R. Stauffer, Phung L. Ngo, Melissa A. Steinbeiser, Shi‐Shan Mao, Steven S. Carroll, Carolyn Bailey, Dennis Colussi, Michelle Bosserman, Christine Burlein, Jacquelynn J. Cook, Gary R. Sitko, Philip R. Tiller, Cynthia Miller‐Stein, Mark J. Rose, Daniel R. McMasters, Joseph P. Vacca, Harold G. Selnick	2003	38
18	Serum hepcidin but not prohepcidin may be an effective marker for anemia of inflammation (AI) Blood Cells Molecules and Diseases ·Barbra J. Sasu, Hongyan Li, Mark J. Rose, Tara Arvedson, George J. Doellgast, Graham Molineux	2010	34
19	Concerns in the development of an assay for determination of a highly conjugated adsorption-prone compound in human urine Journal of Chromatography B ·Yang Xu, Lihong Du, Mark J. Rose, I. Fu, Eric Woolf, Donald G. Musson	2005	33
20	Establishment of an in Vitro Human Blood-Brain Barrier Model Derived from Induced Pluripotent Stem Cells and Comparison to a Porcine Cell-Based System Cells ·Annalise Di Marco, Domenico Vignone, Odalys Gonzalez Paz, Ivan Fini, Maria Rosaria Battista, Antonella Cellucci, Elena Bracacel, Giulio Auciello, Maria Veneziano, Vinod Khetarpal, Mark J. Rose, Alessandro Rosa, Isabelle Gloaguen, Edith Monteagudo, Todd Herbst, Celia Dominguez, Ignacio Muñoz-Sanjuán	2020	29

About Mark J. Rose

Mark J. Rose is a scholar working on Molecular Biology, Oncology, Cellular and Molecular Neuroscience, Emergency Medicine and Pharmacology, having authored 51 papers that have together received 2.8k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (6 papers), Inflammatory mediators and NSAID effects (5 papers), Biosimilars and Bioanalytical Methods (4 papers), Iron Metabolism and Disorders (4 papers), Trauma and Emergency Care Studies (4 papers), Neuropeptides and Animal Physiology (4 papers), Pesticide Residue Analysis and Safety (3 papers) and Melanoma and MAPK Pathways (3 papers). The work is most often cited by research in Pharmacology (239 citations), Immunology (516 citations), Hematology (261 citations), Pharmacology (373 citations) and Analytical Chemistry (203 citations). Mark J. Rose has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Jerome P. Skelly, Jeffrey Sailstad, Brian Booth, Russell Weiner, C.T. Viswanathan, Surendra K. Bansal, Vinod P. Shah, Anthony J. DeStefano, Patrick G. Swann and Eric Woolf. Their work appears in journals such as Journal of Pharmaceutical and Biomedical Analysis, The AAPS Journal, Journal of Medicinal Chemistry, Journal of Chromatography B and Journal of Pharmaceutical Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Mark J. Rose

Impact in

Papers in i

In The Last Decade

Mark J. Rose

Mark J. Rose's Hit Papers

Peers

Countries citing papers authored by Mark J. Rose

Fields of papers citing papers by Mark J. Rose

All Works

About Mark J. Rose

Explore authors with similar magnitude of impact

Papers in